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Sarcoidose is a rare disease in children. The aminotransaminase level is often normal to moderately elevated (2 to 3 folds of the
normal level). We report the case of a child who presented an aminotransaminase level that was 10 times the normal level, as the
ﬁrst manifestation of sarcoidosis.
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1.Introduction
Sarcoidosis is a chronic multisystem, granulomatous disor-
der of unknown etiology [1]. It occurs mainly in adults,
with estimated prevalences ranging from <1t o4 0c a s e s
per 100000 population [2]. Milman et al. recently reported
that the approximate calculated incidence of sarcoidosis in
children in Denmark was 0.27 per 100000 children per year
[3].
In cases of hepatic sarcoidosis, aminotransaminase levels
are normal to moderately elevated (2- to 3-folds of the
normal level) [4, 5]. Usually this abnormality is not the ﬁrst
manifestation of sarcoidosis.
We report the case of a child who presented with an
aminotransaminase level that was 10 times the normal level,
as the ﬁrst manifestation of sarcoidosis.
2.CaseReport
A 13-year-old boy was referred to our institution for
evaluation of elevated aminotransaminases and γ-glutamyl
transpeptidase. He presented with weight loss (10Kg in one
year) and anorexia. There was no evidence of pulmonal
or neurological symptoms. There was no evidence of any
preceding medication. The father and the mother of the
patient have a hepatitis B.
The consistence of liver was normal, and it was palpable
below the costal margin (+3cm). Physical examination was
otherwise unremarkable.
Laboratory testing showed serum aspartate transaminase
of 127U/L, serum alanine transaminase of 496U/L, γ-
glutamyl transpeptidase of 121U/L, total serum bilirubin
of 7μmol/L, serum albumin of 33.53g/L (normal 37–50),
serum LDH of 227U/L (normal 135–345), and a normal
serum INR. No evidence of viral infections including hepati-
tis A virus, hepatitis B virus, hepatitis C virus, Epstein-Barr
virus,orCytomegaloviruswasfound.Antinuclearantibodies
(ANAs), anti-Smooth muscle antibodies (ASMAs), and
liver-kidney microsomal type 1 (LKM1) antibodies were
negative. Ceruloplasmin serum level was 0.348g/L (normal
0.220–0.610). Ultrasonography showed homogenous hep-
atomegaly, perihepatic, paraaortic, and mesenteric enlarged
l y m p hn o d e s( n o d e ss i z e sw e r e1 0t o2 0m i l l i m e t e r s ) .
A liver biopsy (Figure 1) revealed aggregated epithelioid
histiocytesandmultinucleatedgiantcellswithnoevidenceof
necrosis. These lesions were consisting with nonnecrotizing
granulomas. There was no evidence of iron overload in the
liver biopsy. Tuberculin skin test was negative. Angiotensin-
converting enzyme level (ACE) was 139U/L (normal 8–
52U/L), ESR was 73, and C-reactive protein was 6mg/L.
Thoracic CT-Scan showed numerous enlarged mediastinal
lymph nodes. Ophthalmologic exam was normal.2 Case Reports in Medicine
Figure 1: Nonnecrotizing granulomas of hepatic sarcoidosis.
Systemic sarcoidosis with liver involvement was diag-
nosed, and therapy with corticosteroids 2mg/kg/d per os
was started for 2 weeks. The liver function tests (LFTs)
normalized within 1 week of treatment, and ACE level
normalized within 2 weeks of treatment. The corticosteroids
therapywasdecreasedslowlyto0.1mg/kg/dwithin2months
but then increased to 1mg/kg/d because the LFTs and ACE
levels increased again. One year later, the patient developed
renal interstitial ﬁbrosis and tubular atrophy.
3. Discussion
Many diagnoses must be considered in case of hepatic
cytolysis like [5] acute and chronic hepatitis (viral, drugs,
toxicity, autoimmune), acute obstruction of extrahepatic
biliary tract (such as cholelithiasis), primary and secondary
malignancy (such as lymphoma), benign tumors (hepatic
adenoma, hydatic cyst, etc.), metabolic diseases (Wilson dis-
ease, hemochromatosis), α1-antitrypsin deﬁciency, hepatic
granulomatosis (sarcoidosis, tuberculosis, brucellosis, etc.),
systemic diseases (lupus erythematosus, juvenile dermato-
myositis, juvenile rheumatoid arthritis), and celiac disease.
In our patient case, elevated aminotransaminases was
associatedwithweightlossandanorexia.Inthiscasewemust
ﬁrst consider [6] primary and secondary malignancies (such
as lymphoma). Other diagnoses to consider are [6]s y s t e m i c
pathology (lupus erythematosus, juvenile dermatomyositis,
juvenile rheumatoid arthritis, sarcoidosis, autoimmune hep-
atitis), celiac disease, and infectious diseases (tuberculosis,
brucellosis).The γ-glutamyl transpeptidase of 121U/L (3-
folds the normal level) did not help us reduce the diﬀerential
diagnosis.
Abnormalities of liver function tests (LFTs) in patients
with sarcoidosis include [4]: moderately elevated amino-
transaminases (2- to 3-folds of the normal level) are found
in 20% of patients, moderate anicteric cholestasis (elevated
γ-glutamyl transpeptidase and/or alkaline phosphatase) is
found in 50% to 75% of patients, and rarely, conjugated
bilirubin is found elevated. In our case, the patient presented
with an aminotransaminase level that was 10 times the
normal level.
Ultrasonography is valuable in investigating cytolysis.
Our patient had homogenous hepatomegaly, enlarged peri-
hepatic and mesenteric lymph nodes (node sizes were 10 to
20 millimeters).
The presence of abdominal lymphadenopathies led us
retainthefollowingdiagnoses:lymphoma,sarcoidosis,infec-
tious processes (tuberculosis, brucellosis), and celiac disease.
Abdominal lymphadenopathies are frequently observed
in sarcoidosis. In a study of 11 patients with abdominal or
pelvic lymphadenopathies secondary to sarcoidosis, enlarged
celiac artery nodes were seen in 82% of the cases, porta
hepatis nodes in 73%, paraaortic or paracaval nodes in 73%,
gastrohepatic ligament nodes in 55%, mesenteric nodes in
55%, superior mesenteric artery nodes in 45%, and pelvic
nodes in 33%. Retrocrural nodes were involved in only
18% of the patients [7]. When comparing patients with
sarcoidosis with a group of patients with non-Hodgkin’s
lymphoma, retrocrural nodes were involved more frequently
(70%) in the patients with lymphoma [8]. Mean node size
was also signiﬁcantly smaller in patients with sarcoidosis
than in patients with lymphoma (mean ± SD, 2.6±1.7cmin
sarcoidosis versus 8.0 ± 5.5cm in lymphoma), but diameters
of some nodes in patients with sarcoidosis were as high
as 7.5cm [8]. In tuberculosis patients, abdominal lym-
phadenopathy predilection is for periportal, peripancreatic,
and mesenteric locations [9]. Lymphadenopathy is not a
common presenting feature in patients with celiac disease
but was found in 12% of patients in large series [10].
The size of lymphadenopathies in our patient was in
favor of sarcoidosis more than lymphoma.
Liver biopsy is an important step to assess the etiology
of transaminitis. In our patient, the liver biopsy revealed
numerousnon-necrotizinggranulomas.Hepaticgranulomas
have many causes (Table 1)[ 11]. These involve drugs and
systemic disorders (usually infections) more often than
primary liver disorders. The infections are important to be
recognized because they require speciﬁc treatments. Tuber-
culosisandschistosomiasisarethemostimportantinfectious
culprits worldwide; viral pathogens are less common. Sar-
coidosis is the most important noninfectious cause; the liver
is involved in about two thirds of patients and occasionally
is the dominant clinical manifestation. Granulomas are
much less common in primary liver diseases, of which
primarybiliarycirrhosisistheonlyimportantetiology.Small
granulomas occasionally occur in other liver diseases but
are of no clinical signiﬁcance. Idiopathic granulomatous
hepatitis is a rare syndrome of hepatic granulomas, recurrent
fever, myalgias, fatigue, and other systemic symptoms, often
occurring intermittently for years. Some experts believe that
it is a variant of sarcoidosis [11].
Angiotensin-converting enzyme (ACE) level was 139U/L
(normal8–52U/L).SerumACEisthoughttobeproducedby
the epithelioid cells within sarcoid granulomas. It is elevated
in approximately 60% of patients with sarcoidosis, and its
level is thought to reﬂect whole-body granuloma mass and
disease activity [12, 13].
Etiology for sarcoidosis remains obscure but probably
involves environmental and host factors. Therefore, the
diagnosis of sarcoidosis is currently based on a combinationCase Reports in Medicine 3
Table 1: [11].






Bacterial (actinomycosis, brucellosis, cat-scratch fever, syphilis,
TB∗ and other mycobacteria, tularemia)
Fungal(blastomycosis, cryptococcosis, histoplasmosis)
Parasitic (schistosomiasis∗, toxoplasmosis, visceral larva migrans)




Hodgkin’s lymphoma, polymyalgia rheumatic, and other
connective tissue disorders, sarcoidosis∗
∗Most common causes
of suggestiveclinical featureswithhistologically documented
noncaseating granulomas, in the absence of other known
causes of granuloma formation [14].
In our patient, the presence of elevated aminotransami-
nases, weight loss, anorexia, enlarged perihepatic paraaortic
and mesenteric lymph nodes on ultrasonography, nonnecro-
tizing granulomas on liver biopsy, high level of ACE, and
negative tuberculin skin test was in favor of sarcoidosis.
The treatment of hepatic sarcoidosis depends on clinical
and laboratory disease manifestations. When histological
appearance of noncaseating granulomas is present without
clinical or biochemical liver disease or dysfunction, treat-
ment is not required. When LFTs are abnormal without
any evidence of clinical or laboratory systemic sarcoid
involvement, treatment remains a controversial issue. This
is because untreated patients might demonstrate “sponta-
neous” LFTs improvement [15].
In conclusion, in a pediatric population, the presence
of elevated aminotransaminases (10-folds the normal level)
associated with perihepatic and mesenteric enlarged lymph
nodes must evoke the diagnosis of sarcoidosis.
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